News

Investor Alert for CTO Realty Growth: Legal Rights Information

Investor Alert for CTO Realty Growth: Legal Rights Information

CTO Realty Growth Investors: Important Legal Updates

Investing in real estate can be both rewarding and challenging. Recently, there has been significant news regarding CTO Realty Growth, Inc. (NYSE: CTO). Investors are being urged to pay attention to an ongoing securities class action lawsuit highlighting potential irregularities in the company’s financial practices.

Class Action Lawsuit Details

CTO Realty Growth has been at the center of a securities fraud investigation. Reports indicate that between February 18, 2021, and June 24, 2025, investors who acquired securities from the company may have been adversely affected by misleading financial disclosures. Following a report from Wolfpack Research, CEO of CTO faced allegations of financial manipulation that raised concerns about the company's true financial health.

Current Allegations Against CTO Realty Growth

The allegations asserted that on June 25, 2025, a report surfaced accusing CTO of using questionable methods to conceal financial issues. The report indicated that the company covered a substantial dividend gap of $38 million by resorting to share dilution and misrepresenting essential recurring expenses in its Adjusted Funds From Operations. This metric is critical for gauging a real estate investment trust's (REIT) profitability.

Impact on CTO Stock

As a result of these revelations, the stock price of CTO Realty Growth plunged nearly 6%, reaching a closing price of $17.10 on June 25, 2025. Such a downturn indicates the marked impact on investor confidence and the company's market position. For anyone invested in CTO, it is crucial to stay informed about these developments and consider the impacts on their investments.

Leading the Charge: Investor Rights

Investors who acquired CTO securities within the specified class period are encouraged to take action. They have until October 7, 2025, to seek representation as lead plaintiffs in the class action. Understanding your rights as an investor during such turbulent times is essential. Many who are affected have found it beneficial to connect with legal experts who specialize in securities litigation.

Steps for Investors

If you believe your investments in CTO Realty Growth may have been compromised due to misinformation, it is crucial to examine your options. Engaging with legal experts can provide clarity on your potential claims and support throughout the process.

Berger Montague: Your Legal Partner

Berger Montague PC is available to assist CTO investors in understanding their rights in light of the recent lawsuit. Having focused on securities litigation for decades, they are equipped to guide you through the complexities of the case and represent your best interests.

Contact Information

For those seeking more information or advice, reaching out to Berger Montague is a prudent move. Andrew Abramowitz and Caitlin Adorni are key contacts ready to provide guidance. They emphasize the importance of addressing any concerns regarding your investments swiftly and effectively.

Frequently Asked Questions

What is the deadline for filing claims related to this lawsuit?

The deadline for investors to seek appointment as lead plaintiffs is October 7, 2025.

What are the allegations against CTO Realty Growth?

CTO is accused of manipulating financial records and misleading investors regarding its actual financial performance.

How much did CTO's stock fall after the report?

CTO's stock dropped nearly 6%, closing at $17.10 following the allegations.

Who can file a claim in this class action?

Investors who purchased CTO securities during the class period from February 18, 2021, to June 24, 2025, may file claims.

How can I contact Berger Montague for assistance?

You can reach Andrew Abramowitz or Caitlin Adorni at Berger Montague for support regarding your legal options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 58

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Extra Mile Day: 18 Years of Honoring Unsung Heroes

Updated Category News Views 49

Pedaling for Purpose: A Journey That Sparked a Movement What started as a lone journey across America's roads has turned into a celebrated movement to honor those who often go unnoticed. Back in 2009, Shawn Anderson embarked on an unusual journey. Armed only with a bicycle and determination, he pedaled from San Francisco to Boston—over 4,000 miles in just 90 days. It...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Nelson Peltz Doubles Down: Burgers or Pucks?

Updated Category News Views 53

Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 128

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Virginia Cancer Specialists: Leaders in Trusted Cancer Care

Updated Category News Views 42

Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 44

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 58

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 102

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
Heritage Wines Meet Non-Alcoholic Trend: New Deal

Updated Category News Views 49

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...

Continue Reading

Top 5 Most Recently Viewed Articles

Infortar's Share Buyback Strategy and Recent Transactions

Updated Category News Views 176

Infortar's Share Buyback Strategy Infortar is actively engaging in a share buyback program on the Nasdaq Tallinn Stock Exchange. This initiative reflects a strategic approach towards securing and stabilizing their market presence. During a recent period, Infortar made notable acquisitions of its own shares, an activity that signals confidence in its long-term value....

Continue Reading
Cisco's Stock Surges to New Heights Amid Innovative Growth

Updated Category News Views 349

Cisco Sets New Milestone with 52-Week High Cisco Systems Inc (NASDAQ: CSCO) has achieved a remarkable milestone as its shares soared to a 52-week high of $60.23. This surge reflects the company's impressive growth trajectory and consistent performance over the past year. With a current market capitalization of $239.6 billion, analysts suggest that the stock may be...

Continue Reading
Insight into Life Science REIT Plc's Recent Disclosure Process

Updated Category News Views 124

Understanding the Disclosure Process for Life Science REIT Plc The disclosure of relevant securities for companies listed on the stock exchange is crucial for maintaining transparency and regulatory compliance. One important example is the recent public opening position disclosure by Life Science REIT Plc, a notable name in the real estate investment trust sector. This...

Continue Reading
November Energy Stocks Worth Watching: High Potential Picks

Updated Category News Views 874

Opportunities in Oversold Energy Stocks In the energy sector, there is often potential for long-term gains hidden within oversold stocks. When a stock exhibits an oversold condition, it's usually an indicator that investor sentiment has driven the price down more than justified by the company's fundamentals. This presents a buy opportunity for savvy investors....

Continue Reading
Terranet's Technology Development Progress Report

Updated Category News Views 104

Terranet's Technology Development Progress Report Recently, Terranet has shared updates with stakeholders regarding its advancements in technology during the second quarter. The company has begun the initial integration of its system into a vehicle, which will lead to an expanded testing phase that will be reported back to the market. The analyses confirm that the ongoing...

Continue Reading